Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne-Christine Rat

Showing results (31-40 of 93) with videos related to

Pageof 10
Sort By:
The Journal of Rheumatology|August 13, 2003
Information on diagnosis and management of systemic lupus erythematosus derived from the routine measurement of 8 nuclear autoantibodiesGheorghe Paul Ignat, Anne-Christine Rat, Jerry J Sychra, et al.
Thrombosis Research|May 17, 2013
Superficial vein thrombosis, thrombin generation and activated protein C resistance as predictors of thromboembolic events in lupus and antiphospholipid patients. A prospective cohort studyStéphane Zuily, Véronique Regnault, Francis Guillemin, et al.
Rheumatology (Oxford, England)|October 25, 2012
Who are the patients with early arthritis with worse than death scores on the EQ-5D? Results from the ESPOIR cohortCécile Gaujoux-Viala, Bruno Fautrel, Francis Guillemin, et al.
Joint Bone Spine|May 25, 2002
Spinal epidural lipomatosis revealing endogenous Cushing's syndromeDominique Dumont-Fischer, Anne-Christine Rat, Nathalie Saidenberg-Kermanac'h, et al.
Rheumatology (Oxford, England)|July 19, 2013
GUEPARD treat-to-target strategy is significantly more efficacious than ESPOIR routine care in early rheumatoid arthritis according to patient-reported outcomes and physician global estimateIsabel Castrejón, Theodore Pincus, Martin Soubrier, et al.
International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care|September 19, 2007
Content of quality-of-life instruments is affected by item-generation methodsAnne-Christine Rat, Jacques Pouchot, Francis Guillemin, et al.
Pharmacoeconomics|July 27, 2018
Cost Effectiveness of Intra-Articular Hyaluronic Acid and Disease-Modifying Drugs in Knee OsteoarthritisJean-Hugues Salmon, Anne-Christine Rat, Isabelle Charlot-Lambrecht, et al.
Arthritis Care & Research|March 2, 2010
Total hip or knee replacement for osteoarthritis: mid- and long-term quality of lifeAnne-Christine Rat, Francis Guillemin, Georges Osnowycz, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 6, 2019
Impact of comorbidities and functional impairment on 5-year loss of health utility in patients with lower-limb osteoarthritis in the KHOALA cohortAbdou Y Omorou, Hamza Achit, Maud Wieczorek, et al.
Joint Bone Spine|August 7, 2020
Time to initiation of biologic disease-modifying antirheumatic drugs in the French cohort ESPOIRJoanna Kedra, Benjamin Granger, Stéphanie Emilie, et al.
Pageof 10

Showing results (31-40 of 93) with videos related to

Sort By:
Pageof 10
The Journal of Rheumatology|August 13, 2003
Information on diagnosis and management of systemic lupus erythematosus derived from the routine measurement of 8 nuclear autoantibodiesGheorghe Paul Ignat, Anne-Christine Rat, Jerry J Sychra, et al.
Thrombosis Research|May 17, 2013
Superficial vein thrombosis, thrombin generation and activated protein C resistance as predictors of thromboembolic events in lupus and antiphospholipid patients. A prospective cohort studyStéphane Zuily, Véronique Regnault, Francis Guillemin, et al.
Rheumatology (Oxford, England)|October 25, 2012
Who are the patients with early arthritis with worse than death scores on the EQ-5D? Results from the ESPOIR cohortCécile Gaujoux-Viala, Bruno Fautrel, Francis Guillemin, et al.
Joint Bone Spine|May 25, 2002
Spinal epidural lipomatosis revealing endogenous Cushing's syndromeDominique Dumont-Fischer, Anne-Christine Rat, Nathalie Saidenberg-Kermanac'h, et al.
Rheumatology (Oxford, England)|July 19, 2013
GUEPARD treat-to-target strategy is significantly more efficacious than ESPOIR routine care in early rheumatoid arthritis according to patient-reported outcomes and physician global estimateIsabel Castrejón, Theodore Pincus, Martin Soubrier, et al.
International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care|September 19, 2007
Content of quality-of-life instruments is affected by item-generation methodsAnne-Christine Rat, Jacques Pouchot, Francis Guillemin, et al.
Pharmacoeconomics|July 27, 2018
Cost Effectiveness of Intra-Articular Hyaluronic Acid and Disease-Modifying Drugs in Knee OsteoarthritisJean-Hugues Salmon, Anne-Christine Rat, Isabelle Charlot-Lambrecht, et al.
Arthritis Care & Research|March 2, 2010
Total hip or knee replacement for osteoarthritis: mid- and long-term quality of lifeAnne-Christine Rat, Francis Guillemin, Georges Osnowycz, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 6, 2019
Impact of comorbidities and functional impairment on 5-year loss of health utility in patients with lower-limb osteoarthritis in the KHOALA cohortAbdou Y Omorou, Hamza Achit, Maud Wieczorek, et al.
Joint Bone Spine|August 7, 2020
Time to initiation of biologic disease-modifying antirheumatic drugs in the French cohort ESPOIRJoanna Kedra, Benjamin Granger, Stéphanie Emilie, et al.
Pageof 10